Showing 651-660 of 5646 results for "".
“Doctor” Title Under Fire in Some States
https://modernod.com/articles/significant-findings/doctor-title-under-fire-in-some-states/37729/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatCOVID Linked to Rise in Myopia in China
https://modernod.com/articles/significant-findings/covid-linked-to-rise-in-myopia-in-china/37728/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatTwo More Eye Drop Brands Recalled
https://modernod.com/articles/significant-findings/two-more-eye-drop-brands-recalled/37727/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatTRP’n Out: OSD, Inflammation, and Nerves
https://modernod.com/topics/ocular-surface/trpn-out-osd-inflammation-and-nerves/38581/A primer on TRPs and RASP inhibitors.Promising Safety Results With Investigational Dry Eye Drop
https://modernod.com/articles/significant-findings/promising-safety-results-with-investigational-dry-eye-drop/37726/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatInvolving Patients in Their Care
https://modernod.com/articles/significant-findings/involving-patients-in-their-care/37725/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPDUFA Date Approaches for Apellis Drug
https://modernod.com/articles/significant-findings/pdufa-date-approaches-for-apellis-drug/37722/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatArtificial Tear Brand Linked to Eye Infections
https://modernod.com/articles/significant-findings/artificial-tear-brand-linked-to-eye-infections/37721/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatA Renewed Appreciation for Refractions
https://modernod.com/articles/significant-findings/a-renewed-appreciation-for-refractions/37719/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatKnow Your Monoclonal Antibodies
https://modernod.com/topics/nutritionpharmaceuticals/know-your-monoclonal-antibodies/38531/These pharmaceutical agents are used to treat a variety of ocular diseases. Knowing how they’re dosed and their potential side effects will serve you and your patients well.